Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
66 hedge funds and large institutions have $100M invested in Calithera Biosciences, Inc in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 15 closing their positions.
273% more call options, than puts
Call options by funds: $1.23M | Put options by funds: $330K
5% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 22
1% more capital invested
Capital invested by funds: $98.5M → $100M (+$1.47M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 76 → 66 (-10)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.22M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$901K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$869K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$783K |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$663K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.99M |
| 2 |
Morgan Stanley
New York
|
-$2.04M |
| 3 |
Millennium Management
New York
|
-$1.02M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$765K |
| 5 |
Renaissance Technologies
New York
|
-$747K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Prudential Financial
Newark,
New Jersey
| – | -$29K | -696 | Closed |
|
77
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -163 | Closed |
|
|
PAM
78
Panagora Asset Management
Boston,
Massachusetts
| – | -$5K | -128 | Closed |
|
|
CSS
79
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$5K | -108 | Closed |
|
80
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -28 | Closed |
|
81
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -22 | Closed |
|
CALA Hedge Fund Activity: Q3 2021 in Review
66 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2021, worth a combined $100M — up 1.5% from $98.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CALA and 6 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 23 added.
The largest buyer was Citadel Advisors, adding an estimated $2.22M. The largest seller was Adage Capital Partners, cutting an estimated $3.99M.
- 66 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2021, down from 76 in Q2 2021.
- Funds reported $100M of Calithera Biosciences, Inc stock for Q3 2021, up 1.5% quarter-over-quarter.
- 6 funds opened new Calithera Biosciences, Inc positions in Q3 2021 and 15 closed out, a net change of -9 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2021 was Citadel Advisors, an estimated $2.22M added.
- The largest Calithera Biosciences, Inc seller in Q3 2021 was Adage Capital Partners, an estimated $3.99M sold.
Based on aggregated 13F filings for Q3 2021.